U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034261) titled 'Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes' on June 13.
Brief Summary: The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Gestational Diabetes
Intervention:
DEVICE: Blinded Continuous Glucose Monitoring Device
Subjects will be asked to wear blinded continuous glucose monitoring device for 14 days.
Recruitment Status: NOT_YET_REC...